2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      How Synthesis of Algal Nanoparticles Affects Cancer Therapy? – A Complete Review of the Literature

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The necessity to engineer sustainable nanomaterials for the environment and human health has recently increased. Due to their abundance, fast growth, easy cultivation, biocompatibility and richness of secondary metabolites, algae are valuable biological source for the green synthesis of nanoparticles (NPs). The aim of this review is to demonstrate the feasibility of using algal-based NPs for cancer treatment. Blue-green, brown, red and green micro- and macro-algae are the most commonly participating algae in the green synthesis of NPs. In this process, many algal bioactive compounds, such as proteins, carbohydrates, lipids, alkaloids, flavonoids and phenols, can catalyze the reduction of metal ions to NPs. In addition, many driving factors, including pH, temperature, duration, static conditions and substrate concentration, are involved to facilitate the green synthesis of algal-based NPs. Here, the biosynthesis, mechanisms and applications of algal-synthesized NPs in cancer therapy have been critically discussed. We also reviewed the effective role of algal synthesized NPs as anticancer treatment against human breast, colon and lung cancers and carcinoma.

          Related collections

          Most cited references334

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Nano based drug delivery systems: recent developments and future prospects

            Nanomedicine and nano delivery systems are a relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. Recently, there are a number of outstanding applications of the nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents etc.) in the treatment of various diseases. The current review, presents an updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and selective diagnosis through disease marker molecules. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications are also discussed. In addition, we have included information regarding the trends and perspectives in nanomedicine area.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found
              Is Open Access

              Nanoparticles: Properties, applications and toxicities

                Bookmark

                Author and article information

                Journal
                Int J Nanomedicine
                Int J Nanomedicine
                ijn
                International Journal of Nanomedicine
                Dove
                1176-9114
                1178-2013
                10 November 2023
                2023
                : 18
                : 6601-6638
                Affiliations
                [1 ]Botany Department, Faculty of Science, Tanta University , Tanta, 31527, Egypt
                [2 ]Molecular Cell Biology Unit, Division of Biochemistry, Chemistry Department, Faculty of Science, Tanta University , Tanta, 31527, Egypt
                [3 ]Plastic Surgery Department, Faculty of Medicine, Tanta University , Tanta, 31527, Egypt
                [4 ]Department of Agricultural Microbiology, Faculty of Agriculture, Zagazig University , Zagazig, 44511, Egypt
                [5 ]Department of Biology, College of Science, United Arab Emirates University , Al Ain, 15551, United Arab Emirates
                Author notes
                Correspondence: Synan F AbuQamar; Khaled A El-Tarabily, Department of Biology, College of Science, United Arab Emirates University , Al Ain, 15551, United Arab Emirates, Tel +971 3 713 6733; +971 3 713 6518, Fax +971 3 713 4927, Email sabuqamar@uaeu.ac.ae; ktarabily@uaeu.ac.ae
                Author information
                http://orcid.org/0000-0002-2298-6312
                http://orcid.org/0000-0002-7303-1444
                http://orcid.org/0000-0001-8633-1836
                http://orcid.org/0000-0002-2129-7689
                http://orcid.org/0000-0002-8189-7088
                Article
                423171
                10.2147/IJN.S423171
                10644851
                0a8a385b-5993-4c1f-846a-a89faf8c3b81
                © 2023 El-Sheekh et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 22 June 2023
                : 22 September 2023
                Page count
                Figures: 5, Tables: 7, References: 334, Pages: 38
                Funding
                Funded by: Abu Dhabi Award for Research Excellence—Department of Education and Knowledge (Grant #: 21S105) to K El-Tarabily, and Khalifa Center for Biotechnology and Genetic Engineering—UAEU (Grant #: 31R286) to S. AbuQamar;
                This review was funded by Abu Dhabi Award for Research Excellence—Department of Education and Knowledge (Grant #: 21S105) to K El-Tarabily, and Khalifa Center for Biotechnology and Genetic Engineering—UAEU (Grant #: 31R286) to S. AbuQamar.
                Categories
                Review

                Molecular medicine
                algae,metabolites,cancer therapy,green synthesis,medical applications,nanoparticles
                Molecular medicine
                algae, metabolites, cancer therapy, green synthesis, medical applications, nanoparticles

                Comments

                Comment on this article